Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

4.21
Delayed Data
As of May 24
 -0.06 / -1.41%
Today’s Change
2.96
Today|||52-Week Range
29.94
-73.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
AssetsCash81.6M66.8M72.1M63.0M
 
 
 
 
 
Short Term Investment Cash-40.6M-14.8M5.3M-9.1M
 
 
 
 
 
Cash & Short Term Investments334.0M303.4M289.9M254.0M
 
 
 
 
 
 
ReceivablesReceivables434.0K1.7M970.0K847.0K
 
 
 
 
 
 
InventoriesInventories--0.000.000.00--
 
Current AssetsOther Current Assets5.1M4.1M4.1M6.1M
 
 
 
 
 
Current Assets339.5M309.3M294.9M261.0M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross11.7M11.9M28.5M--
 
 
 
 
Depreciation-----17.1M--
 
 
Intangible Assets30.3M30.0M29.8M29.5M
 
 
 
 
 
Other Assets31.9M31.5M31.2M29.6M
 
 
 
 
 
Total Assets383.2M352.6M337.6M301.9M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.0M1.2M1.5M2.6M
 
 
 
 
 
Accrued Expenses21.9M19.6M18.7M18.4M
 
 
 
 
 
Other Current Liabilities24.7M22.4M23.1M22.7M
 
 
 
 
 
Other Liabilities26.7M23.6M30.2M25.3M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities10.6M10.4M17.2M16.6M
 
 
 
 
 
Total Liabilities37.3M34.0M47.5M41.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity345.9M318.6M290.1M260.0M
 
 
 
 
 
Total Shareholder Equity345.9M318.6M290.1M260.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding98.5M98.6M98.7M98.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.